Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Vaccines

Free Subscription Articles published in Proc Natl Acad Sci U S A Retrieve available abstracts of 38 articles: HTML format

Single Articles

October 2025
1. LV H, Teo QW, Pholcharee T, Liu W, et al
   Molecular divergence and convergence of mammalian antibody responses to the influenza virus hemagglutinin stem.
   Proc Natl Acad Sci U S A. 2025;122:e2510927122.
   PubMed     Abstract available
   
   
   September 2025
2. REUBER EE, Hickey E, Pradhan A, Sprute R, et al
   Glycan microarray analysis of Candida-related antibodies in human and mice sera guides biomarker discovery and vaccine development.
   Proc Natl Acad Sci U S A. 2025;122:e2505340122.
   PubMed     Abstract available
   
   
   
3. MORIYAMA M, Rodrigues G, Wang J, Jayewickreme R, et al
   Intranasal hemagglutinin protein boosters induce protective mucosal immunity against influenza A viruses in mice.
   Proc Natl Acad Sci U S A. 2025;122:e2422171122.
   PubMed     Abstract available
   
   
   
4. VILLAREJO-TORRES M, Nombela-Diaz I, Munoz-Santos D, Ruiz-Yuste M, et al
   SARS-CoV-2-derived RNA replicons as safe and effective vaccines.
   Proc Natl Acad Sci U S A. 2025;122:e2516587122.
   PubMed     Abstract available
   
   
   
5. SWINGLE KL, Hamilton AG, Han X, Liao KC, et al
   Circular RNA lipid nanoparticle vaccine against SARS-CoV-2.
   Proc Natl Acad Sci U S A. 2025;122:e2505718122.
   PubMed     Abstract available
   
   
   
6. WANG S, Sun H, Wang Y, Wang Z, et al
   Broad neutralizing antibody response of a monomeric spike-based SARS-CoV-2 bivalent vaccine against diverse variants.
   Proc Natl Acad Sci U S A. 2025;122:e2503254122.
   PubMed     Abstract available
   
   
   August 2025
7. LIN X, Cottrell CA, Kalyuzhniy O, Tingle R, et al
   Structural insights into VRC01-class bnAb precursors with diverse light chains elicited in the IAVI G001 human vaccine trial.
   Proc Natl Acad Sci U S A. 2025;122:e2510163122.
   PubMed     Abstract available
   
   
   
8. HSU CC, Chamblee M, Ye C, Shamseldin MM, et al
   Intranasal measles virus- and mumps virus-based SARS-CoV-2 vaccine candidates prevent SARS-CoV-2 infection and transmission.
   Proc Natl Acad Sci U S A. 2025;122:e2506821122.
   PubMed     Abstract available
   
   
   
9. MCGUIRE DJ, Akondy RS, Yang S, Edupuganti S, et al
   Regulation of CD45 isoforms during human effector and memory CD8 T cell differentiation: Implications for T cell nomenclature.
   Proc Natl Acad Sci U S A. 2025;122:e2322982122.
   PubMed     Abstract available
   
   
   July 2025
10. RIDELFI M, Vezzani G, Roscioli E, Batani G, et al
    A multifunctional anti-O-Antigen human monoclonal antibody protects against Shigella sonnei infection in vivo.
    Proc Natl Acad Sci U S A. 2025;122:e2426211122.
    PubMed     Abstract available
    
    
    May 2025
11. WINHEIM E, Santos-Peral A, Ehm T, Rinke L, et al
    Interferon-induced activation of dendritic cells and monocytes by yellow fever vaccination correlates with early antibody responses.
    Proc Natl Acad Sci U S A. 2025;122:e2422236122.
    PubMed     Abstract available
    
    
    April 2025
12. RADIC L, Offersgaard A, Kadava T, Zon I, et al
    Bispecific antibodies against the hepatitis C virus E1E2 envelope glycoprotein.
    Proc Natl Acad Sci U S A. 2025;122:e2420402122.
    PubMed     Abstract available
    
    
    March 2025
13. GAILLETON R, Mathew NR, Reusch L, Schon K, et al
    Ectopic germinal centers in the nasal turbinates contribute to B cell immunity to intranasal viral infection and vaccination.
    Proc Natl Acad Sci U S A. 2025;122:e2421724122.
    PubMed     Abstract available
    
    
    
14. 
    Correction for Chen et al., Live-attenuated virus vaccine defective in RNAi suppression induces rapid protection in neonatal and adult mice lacking mature B and T cells.
    Proc Natl Acad Sci U S A. 2025;122:e2502986122.
    PubMed    
    
    
    
15. TORGBOR C, Sohn H, Dizon BLP, Mutic EC, et al
    In the activation of HPV-specific human B cells HPV-VLP vaccines mimic membrane-associated antigens.
    Proc Natl Acad Sci U S A. 2025;122:e2414514122.
    PubMed     Abstract available
    
    
    February 2025
16. NGUYEN YTK, Zhu X, Han J, Rodriguez AJ, et al
    Structural characterization of influenza group 1 chimeric hemagglutinins as broad vaccine immunogens.
    Proc Natl Acad Sci U S A. 2025;122:e2416628122.
    PubMed     Abstract available
    
    
    January 2025
17. 
    Correction for Mehmood et al., Teacher vaccinations enhance student achievement in Pakistan: The role of role models and theory of mind.
    Proc Natl Acad Sci U S A. 2025;122:e2424809121.
    PubMed    
    
    
    December 2024
18. MEHRA S, Nosten F, Luxemburger C, White NJ, et al
    Modeling the within-host dynamics of Plasmodium vivax hypnozoite activation: An analysis of the SPf66 vaccine trial.
    Proc Natl Acad Sci U S A. 2024;121:e2401024121.
    PubMed     Abstract available
    
    
    
19. ABT ER, Lam AK, Noguchi M, Rashid K, et al
    Staggered immunization with mRNA vaccines encoding SARS-CoV-2 polymerase or spike antigens broadens the T cell epitope repertoire.
    Proc Natl Acad Sci U S A. 2024;121:e2406332121.
    PubMed     Abstract available
    
    
    November 2024
20. MEHMOOD S, Naseer S, Chen DL
    Teacher vaccinations enhance student achievement in Pakistan: The role of role models and theory of mind.
    Proc Natl Acad Sci U S A. 2024;121:e2406034121.
    PubMed     Abstract available
    
    
    
21. SOBRAL MC, Cabizzosu L, Kang SJ, Ruark K, et al
    IL-2/anti-IL-2 antibody complexes augment immune responses to therapeutic cancer vaccines.
    Proc Natl Acad Sci U S A. 2024;121:e2322356121.
    PubMed     Abstract available
    
    
    
22. LOOMIS RJ, Lai YT, Sowers SB, Fisher B, et al
    Structure-based design of glycoprotein subunit vaccines for mumps.
    Proc Natl Acad Sci U S A. 2024;121:e2404053121.
    PubMed     Abstract available
    
    
    October 2024
23. WAN J, Wang C, Wang Z, Wang L, et al
    CXCL13 promotes broad immune responses induced by circular RNA vaccines.
    Proc Natl Acad Sci U S A. 2024;121:e2406434121.
    PubMed     Abstract available
    
    
    
24. PARK SW, Lawal T, Marin M, Marlow MA, et al
    Modeling the population-level impact of a third dose of MMR vaccine on a mumps outbreak at the University of Iowa.
    Proc Natl Acad Sci U S A. 2024;121:e2403808121.
    PubMed     Abstract available
    
    
    
25. FITZGERALD J
    US states that mandated COVID-19 vaccination see higher, not lower, take-up of COVID-19 boosters and flu vaccines.
    Proc Natl Acad Sci U S A. 2024;121:e2403758121.
    PubMed    
    
    
    
26. RAINS SA, Richards AS
    Reply to Fitzgerald: COVID-19 vaccine mandates and voluntary vaccination behavior.
    Proc Natl Acad Sci U S A. 2024;121:e2409246121.
    PubMed    
    
    
    September 2024
27. SPONHOLTZ MR, Byrne PO, Lee AG, Ramamohan AR, et al
    Structure-based design of a soluble human cytomegalovirus glycoprotein B antigen stabilized in a prefusion-like conformation.
    Proc Natl Acad Sci U S A. 2024;121:e2404250121.
    PubMed     Abstract available
    
    
    
28. WANG X, Dou Y, Hu J, Chan CH, et al
    Conserved moonlighting protein pyruvate dehydrogenase induces robust protection against Staphylococcus aureus infection.
    Proc Natl Acad Sci U S A. 2024;121:e2321939121.
    PubMed     Abstract available
    
    
    August 2024
29. ABBATE MF, Dupic T, Vigne E, Shahsavarian MA, et al
    Computational detection of antigen-specific B cell receptors following immunization.
    Proc Natl Acad Sci U S A. 2024;121:e2401058121.
    PubMed     Abstract available
    
    
    July 2024
30. HU Z, Lopez-Munoz AD, Kosik I, Li T, et al
    Recombinant OC43 SARS-CoV-2 spike replacement virus: An improved BSL-2 proxy virus for SARS-CoV-2 neutralization assays.
    Proc Natl Acad Sci U S A. 2024;121:e2310421121.
    PubMed     Abstract available
    
    
    
31. PURCELL H, Kohler IV, Ciancio A, Mwera J, et al
    Mortality risk information and health-seeking behavior during an epidemic.
    Proc Natl Acad Sci U S A. 2024;121:e2315677121.
    PubMed     Abstract available
    
    
    June 2024
32. TORTORICE D, Rappuoli R, Bloom DE
    The economic case for scaling up health research and development: Lessons from the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2024;121:e2321978121.
    PubMed     Abstract available
    
    
    
33. WANG Y, Qu J, Xiong C, Chen B, et al
    Transdermal microarrayed electroporation for enhanced cancer immunotherapy based on DNA vaccination.
    Proc Natl Acad Sci U S A. 2024;121:e2322264121.
    PubMed     Abstract available
    
    
    
34. AFROZ S, Saul S, Dai J, Surman S, et al
    Human parainfluenza virus 3 vaccine candidates attenuated by codon-pair deoptimization are immunogenic and protective in hamsters.
    Proc Natl Acad Sci U S A. 2024;121:e2316376121.
    PubMed     Abstract available
    
    
    May 2024
35. WU C, Raheem IT, Nahas DD, Citron M, et al
    Stabilized trimeric peptide immunogens of the complete HIV-1 gp41 N-heptad repeat and their use as HIV-1 vaccine candidates.
    Proc Natl Acad Sci U S A. 2024;121:e2317230121.
    PubMed     Abstract available
    
    
    April 2024
36. CHEN G, Han Q, Li WX, Hai R, et al
    Live-attenuated virus vaccine defective in RNAi suppression induces rapid protection in neonatal and adult mice lacking mature B and T cells.
    Proc Natl Acad Sci U S A. 2024;121:e2321170121.
    PubMed     Abstract available
    
    
    
37. FREEDMAN AS, Sheen JK, Tsai S, Yao J, et al
    Inferring COVID-19 testing and vaccination behavior from New Jersey testing data.
    Proc Natl Acad Sci U S A. 2024;121:e2314357121.
    PubMed     Abstract available
    
    
    March 2024
38. CHANG S, Shin KS, Park B, Park S, et al
    Strategy to develop broadly effective multivalent COVID-19 vaccines against emerging variants based on Ad5/35 platform.
    Proc Natl Acad Sci U S A. 2024;121:e2313681121.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.